Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Carboplatin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 57 Lung Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 17 Breast Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasm Metastasis 15 Fallopian Tube Neoplasms 14 Ovarian Neoplasms 13 Small Cell Lung Carcinoma 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Neoplasms 8 Endometrial Neoplasms 8 Head and Neck Neoplasms 7 Carcinoma, Transitional Cell 7 Urinary Bladder Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Oropharyngeal Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Carcinoma 5 Uterine Cervical Neoplasms 4 Recurrence 4 Carcinoma, Squamous Cell 4 Mouth Neoplasms 3 Mesothelioma 3 Melanoma 3 Laryngeal Neoplasms 3 Uterine Neoplasms 2

Interventions

blinatumomab 2 Melphalan 2 Cyclophosphamide 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 pembrolizumab 1 palbociclib 1 nilotinib 1 fludarabine phosphate 1 fludarabine 1 avelumab 1 Whole-Body Irradiation 1 Trastuzumab 1 Sirolimus 1 Rituximab 1 Radiotherapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1 Monatide (IMS 3015) 1 Levetiracetam 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Hematologic Tests 1 HMPL-013 1 Dasatinib 1 Cytarabine 1 Capecitabine 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡